Skip to main content

Showing results for Cancer

Cancer center researcher receives $1.3 million grant to improve breast cancer treatment for Black women

An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher is identifying the unique biology that may make Black women more susceptible to aggressive breast cancer.

IU School of Medicine  |  Nov 18, 2020

IU researcher receives $2.9 million for work improving effectiveness in lung cancer radiation therapy

An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher has been awarded a five-year, $2.9 million grant from the National Cancer Institute to develop a drug that could make radiation therapy far more effective.

IU School of Medicine  |  Nov 10, 2020

Walther Cancer Foundation $11 million investment to expand IU-Purdue bioinformatics collaboration

The Walther Cancer Foundation will invest $11 million to advance collaborative cancer research at Indiana University and Purdue University by supporting scientists through bioinformatics — an increasingly critical aspect of their work.

IU School of Medicine  |  Oct 08, 2020

IU School of Medicine names new cancer center director, announces $15 million supporting gift from Walther Cancer Foundation

Indiana University School of Medicine has announced the hiring of a world-recognized medical oncologist and multiple myeloma researcher to lead the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, bolstered by a $15 million fund established by the Walther Cancer Foundation to support him in this role.   

IU School of Medicine  |  Oct 07, 2020

IU cancer center researcher awarded $5.7 million to study chemo-induced hearing loss, toxicities

INDIANAPOLIS -- A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has been awarded a five-year, $5.7 million National Cancer Institute grant to evaluate long-term health outcomes for cancer patients who receive platinum-based chemotherapies. An internationally recognized expert on cancer survivorship, Lois B. Travis, MD, ScD, leads the ongoing study that could lessen cancer treatment side effects for millions of patients. 

IU School of Medicine  |  Sep 02, 2020

IU School of Medicine findings set new standard for use of blood-based biomarkers in clinical trials for prediction of cancer recurrence

Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women’s blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

IU School of Medicine  |  Jul 09, 2020

IU cancer researcher earns $1.6 million NCI grant for multiple myeloma bone disease therapies

An IU Melvin and Bren Simon Comprehensive Cancer Center researcher has been awarded a five-year, $1.6 million grant from the National Cancer Institute to study ways to build bone and decrease tumor growth in multiple myeloma bone disease.

IU School of Medicine  |  May 11, 2020

Cancer center researchers identify checkpoint target for colorectal cancer immunotherapy

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

IU School of Medicine  |  May 07, 2020

Researchers develop publication with collaborator quarantined in China during COVID-19 outbreak

IU School of Medicine scientists published research in Nature Communications this week, overcoming significant obstacles of the current COVID-19 pandemic.

IU School of Medicine  |  Apr 15, 2020

IU cancer researcher identifies new areas in human genomes linked to skin cancer risk

INDIANAPOLIS — An Indiana University cancer researcher has identified eight new genomic regions that increase a person’s risk for skin cancer. Jiali Han, Ph.D., and colleagues discovered eight new loci—locations on a person’s genome—that are susceptible to the development of squamous cell skin cancer. Han is the Rachel Cecile Efroymson Professor in Cancer Research at […]

Michael Schug  |  Feb 18, 2020